After SPDL1 knockdown, the activity of MTs is inhibited, and they become more sensitive to low doses of paclitaxel owing to the prolongation of mitotic time and an increase in the number of multinucleated cells, reinforcing the cytotoxic activity of paclitaxel and facilitating the death of tumor cells [58]. This evidence concerns the gene SPDL1 and neoplasm.